Number of items: 3.
2022
Metzenmacher, Martin,
Hegedüs, Balazs ,
Forster, Jan,
Schramm, Alexander,
Horn, Peter A.,
Klein, Christoph A.,
Bielefeld, Nicola,
Ploenes, Till,
Aigner, Clemens,
Theegarten, Dirk,
Schildhaus, Hans-Ulrich,
Siveke, Jens T.,
Schuler, Martin and
Lueong, Smiths S.
(2022)
Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer.
Translational Oncology 15 (1), p. 101279.
Fulltext not available.
Metzenmacher, Martin ,
Hegedüs, Balazs,
Forster, Jan,
Schramm, Alexander,
Horn, Peter A.,
Klein, Christoph A.,
Bielefeld, Nicola,
Ploenes, Till,
Aigner, Clemens,
Siveke, Jens T.,
Schuler, Martin and
Lueong, Smiths S.
(2022)
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non‐small cell lung cancer.
Thoracic Cancer 13 (15), pp. 2180-2191.
Fulltext not available.
2019
Al-Batran, Salah-Eddin,
Homann, Nils,
Pauligk, Claudia,
Goetze, Thorsten O.,
Meiler, Johannes,
Kasper, Stefan,
Kopp, Hans-Georg,
Mayer, Frank,
Haag, Georg Martin,
Luley, Kim,
Lindig, Udo,
Schmiegel, Wolff,
Pohl, Michael,
Stoehlmacher, Jan,
Folprecht, Gunnar,
Probst, Stephan,
Prasnikar, Nicole,
Fischbach, Wolfgang,
Mahlberg, Rolf,
Trojan, Jörg,
Koenigsmann, Michael,
Martens, Uwe M.,
Thuss-Patience, Peter,
Egger, Matthias,
Block, Andreas,
Heinemann, Volker,
Illerhaus, Gerald,
Moehler, Markus,
Schenk, Michael,
Kullmann, Frank,
Behringer, Dirk M.,
Heike, Michael,
Pink, Daniel,
Teschendorf, Christian,
Löhr, Carmen,
Bernhard, Helga,
Schuch, Gunter,
Rethwisch, Volker,
von Weikersthal, Ludwig Fischer,
Hartmann, Jörg T.,
Kneba, Michael,
Daum, Severin,
Schulmann, Karsten,
Weniger, Jörg,
Belle, Sebastian,
Gaiser, Timo,
Oduncu, Fuat S.,
Güntner, Martina,
Hozaeel, Wael,
Reichart, Alexander,
Jäger, Elke,
Kraus, Thomas,
Mönig, Stefan,
Bechstein, Wolf O.,
Schuler, Martin,
Schmalenberg, Harald and
Hofheinz, Ralf D.
(2019)
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
The Lancet 393 (10184), pp. 1948-1957.
Fulltext not available.
This list was generated on Wed Nov 13 11:46:12 2024 CET.